FBT First Trust NYSE Arca Biotech ETF
NYSE Arca Biotechnology TR USD

NAV as of 20-May-2022

133.5300

4 Week: 125.11 - 144.49

52 Week: 125.11 - 176.20

Latest Closing Price

133.44

Premium / Discount

-0.01

Expense Ratio

0.55%

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

Main Fund Characteristics

Fund Manager:
First Trust
Asset Under Management:
1,274,128,045
Launch Date:
18/06/2006
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
31
Trading Currency:
USD
Style:
Mid Growth
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-17.611.98-8.90
1 Day0.530.000.00
1 Week0.774.470.17
1 Month-10.9211.89-0.92
3 Months-7.8316.39-0.48
6 Months-16.2820.69-0.79
1 Year-18.6623.63-0.79
2 Years-19.5632.82-0.60
3 Years2.5444.690.06
5 Years25.2556.670.45
10 Years214.4281.242.64

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 40.911950.097747.632810.9658-19.601936.9898-0.208819.782712.9275-2.3271
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 2.000039.00001.000029.000089.000012.000054.000083.000084.000076.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
22/12/201430/12/20140.0524
22/06/200829/06/20080.2697

Portfolio Data

Total Number of Holdings: 31

Number of Bond Holdings: 0

Number of Equity Holdings: 30

Total Market Value: 1,274,128,045

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1United Therapeutics Corp3.3519576,072-43,58266,248,280

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant0.00
Large27.51
Medium48.63
Small15.70
Micro8.03

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

19.0587

Price/Book*

2.8959

Price/Sales*

2.9782

Price/Cash Flow*

13.4043

Dividend Yield*

0.5967

Growth Measures

Long-Term Earnings

20.0168

Historical Earnings

11.9283

Sales Growth

12.1611

Cash-Flow Growth

10.9787

Book-Value Growth

8.4798

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.